会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明专利
    • Enteric granule and method for producing the same
    • 有效颗粒及其制造方法
    • JP2007332101A
    • 2007-12-27
    • JP2006167814
    • 2006-06-16
    • Shin Etsu Chem Co LtdToa Eiyo Ltdトーアエイヨー株式会社信越化学工業株式会社
    • TANJI CHIKANORIMATSUI TADASHIYUASA SHIYUUICHIROUNISHIYAMA YUICHIITO YUICHIFUKUI IKUO
    • A61K47/38A61K9/16A61K47/14
    • A61K9/1688A61K9/1652A61K9/5026A61K9/5042A61K9/5073
    • PROBLEM TO BE SOLVED: To provide enteric granules in which elution to water is suppressed in a low coating amount and to provide a method for producing the enteric granules. SOLUTION: The enteric granules comprise raw granules or granules containing the raw granules and one or more layers for applying the raw granules, a first enteric layer for applying the raw granules or granules and a second enteric layer thereon, and the first enteric layer and the second enteric layer each contains hydroxypropylmethyl cellulose acetate succinate (HPMCAS) which are different in dissolution pH and the dissolution pH of HPMCAS of the second enteric layer is lower than the dissolution pH of HPMCAS of the first enteric layer. The method for producing the enteric granules comprises a step for forming the first enteric layer by coating raw granules or granules containing one or more layers for applying the raw granules with an enteric coating agent containing HPMCAS and a step for forming the second enteric layer on the first enteric layer by using an enteric coating agent containing HPMCAS having dissolution pH which is lower than that of the above HPMCAS. COPYRIGHT: (C)2008,JPO&INPIT
    • 待解决的问题:提供以低涂布量抑制洗脱水的肠溶颗粒,并提供生产肠溶颗粒的方法。 解决方案:肠溶颗粒包含含有原料颗粒的原料颗粒或颗粒和用于施加原料颗粒的一层或多层,用于施加原料颗粒或颗粒的第一肠溶层和其上的第二肠溶层,以及第一肠 层和第二肠溶层各自含有溶解pH不同的羟丙基甲基纤维素乙酸琥珀酸酯(HPMCAS)和第二肠溶层的HPMCAS的溶解pH低于第一肠溶层的HPMCAS的溶解pH。 肠溶颗粒的制造方法包括以下步骤:通过将包含一层或多层的原料颗粒或颗粒用含有HPMCAS的肠溶包衣剂涂敷原料颗粒并在其上形成第二肠溶层的步骤来形成第一肠溶层 通过使用含有低于上述HPMCAS溶出度的pH值的HPMCAS的肠溶包衣剂来进行第一肠溶层。 版权所有(C)2008,JPO&INPIT
    • 2. 发明专利
    • Enteric granule and method for producing the same
    • 有效颗粒及其制造方法
    • JP2007332102A
    • 2007-12-27
    • JP2006167815
    • 2006-06-16
    • Toa Eiyo Ltdトーアエイヨー株式会社
    • TANJI CHIKANORIMATSUI TADASHIYUASA SHIYUUICHIROU
    • A61K31/7076A61K9/62A61K47/14A61K47/38A61P1/04A61P1/08A61P1/14A61P9/04A61P9/08A61P9/10A61P17/00A61P25/00A61P27/02
    • PROBLEM TO BE SOLVED: To provide enteric granules in which elution to water is suppressed in a low coating amount, in the enteric granules containing adenosine triphosphate or its pharmaceutically permissible salt as a pharmaceutically effective component, and to provide a method for producing the enteric granules.
      SOLUTION: The enteric granules comprise raw granules carrying adenosine triphosphate or its pharmaceutically permissible salt as a pharmaceutical effective component or granules containing the raw granules and one or more layers for applying the raw granules, a first enteric layer for applying the raw granules or the granules and a second enteric layer thereon, and the first enteric layer and the second enteric layer each contains hydroxypropylmethyl cellulose acetate succinate (HPMCAS) which are different in dissolution pH and the dissolution pH of HPMCAS of the second enteric layer is lower than the dissolution pH of HPMCAS of the first enteric layer. The method for producing the enteric granules is also provided.
      COPYRIGHT: (C)2008,JPO&INPIT
    • 待解决的问题:为了提供以低涂布量抑制洗脱水的肠溶颗粒,在含有三磷酸腺苷或其药学上允许的盐作为药学上有效成分的肠溶颗粒中,提供一种生产方法 肠溶颗粒。 解决方案:肠溶颗粒包含携带三磷酸腺苷或其药学上可允许的盐作为药物有效成分或含有原料颗粒的颗粒的原料颗粒和用于施加原料颗粒的一层或多层,用于施加原料颗粒的第一肠溶层 或颗粒和第二肠溶层,第一肠溶层和第二肠溶层各自含有溶解pH不同的羟丙基甲基纤维素乙酸琥珀酸酯(HPMCAS)和第二肠溶层的HPMCAS的溶解pH低于 第一肠溶层的HPMCAS的溶出pH。 还提供了生产肠溶颗粒的方法。 版权所有(C)2008,JPO&INPIT
    • 3. 发明专利
    • Bisoprolol-containing adhesive preparation
    • 含双酚A的粘合剂制剂
    • JP2007186499A
    • 2007-07-26
    • JP2006328922
    • 2006-12-06
    • Nitto Denko CorpToa Eiyo Ltdトーアエイヨー株式会社日東電工株式会社
    • IWAO YOSHIHIROOKUBO KATSUYUKIOKADA KATSUHIROMINAMI KUNIHIROYUASA SHIYUUICHIROU
    • A61K47/10A61K9/70A61K31/138A61K47/32A61P25/02
    • A61K9/7053A61K31/138A61K47/10A61K47/32
    • PROBLEM TO BE SOLVED: To provide an adhesive preparation for percutaneously administering free base of bisoprolol into a living body, which uses a polyisobutylene-based adhesive as an adhesive, inhibits the bleeding of the free base of bisoprolol, and has sufficient adhesive characteristics.
      SOLUTION: This bisoprolol-containing adhesive preparation 10 is characterized by laminating an adhesive layer 2 to one side of a support 1. This adhesive layer 2 comprises a 12 to 28C branched monohydric alcohol, the free base of bisoprolol, and a polyisobutylene-based adhesive. Thereby, the compatibility of the polyisobutylene-based adhesive with the free base of the bisoprolol can specifically be enhanced. Consequently, the amount of the free base of the bisoprolol can be increased, and the bleeding of the free base of the bisoprolol from the adhesive layer can be prevented. Sufficiently adhesive characteristics on practical aspects can be obtained.
      COPYRIGHT: (C)2007,JPO&INPIT
    • 要解决的问题:为了提供一种用于将使用聚异丁烯类粘合剂作为粘合剂的比索洛尔的游离碱经皮给药的生物体的粘合剂,抑制比索洛尔的游离碱的渗出,并且具有足够的粘合剂 特点。 解决方案:该含比索洛列的粘合剂制剂10的特征在于将粘合剂层2层压到载体1的一侧。该粘合剂层2包含12至28℃的支链一元醇,比索洛韦的游离碱和聚异丁烯 的粘合剂。 由此,能够提高聚异丁烯类粘合剂与比索洛尔的游离碱的相容性。 因此,可以增加比索洛尔的游离碱的量,并且可以防止比索洛尔的游离碱从粘合剂层渗出。 可以获得实用方面的足够的粘合特性。 版权所有(C)2007,JPO&INPIT
    • 4. 发明专利
    • Adhesive preparation containing bisoprolol
    • 包含双酚的胶体制剂
    • JP2007099759A
    • 2007-04-19
    • JP2006235270
    • 2006-08-31
    • Nitto Denko CorpToa Eiyo Ltdトーアエイヨー株式会社日東電工株式会社
    • IWAO YOSHIHIROOKUBO KATSUYUKIOKADA KATSUHIROMINAMI KUNIHIROYUASA SHIYUUICHIROU
    • A61K31/138A61K9/70A61K47/10A61K47/14A61K47/32A61P9/06A61P9/10A61P9/12A61P43/00
    • A61K31/138A61K9/7053
    • PROBLEM TO BE SOLVED: To provide an adhesive preparation which has a low irritation to the skin surface, excellent in stability of bisoprolol in the preparation and further capable of continuously administrating a pharmacologically effective amount of bisoprolol to the living body. SOLUTION: The adhesive preparation 10 has a support 1 and an adhesive layer 2 which is layered on one surface of the support 1. The adhesive layer 2 is characterized by containing bisoprolol, polyisobutylene, a tackifier and an organic liquid component which is compatible with polyisobutylene and the tackifier. By this, the adhesive preparation having good skin adhesiveness, low skin irritation and reduced pain or adhesive residue at the time of removal from the skin surface can be provided. Further, the adhesive preparation in which the stability of bisoprolol in the adhesive preparation is excellent and the pharmacologically effective amount of bisoprolol can be continuously administrated to the living body through the skin surface is provided. COPYRIGHT: (C)2007,JPO&INPIT
    • 要解决的问题:提供一种对皮肤表面具有低刺激性的粘合剂,比索洛尔在制剂中的稳定性优异,并且还能够将有效量的比索洛尔连续施用于生物体。 粘合剂制剂10具有层叠在载体1的一个表面上的载体1和粘合剂层2.粘合剂层2的特征在于含有比索洛尔,聚异丁烯,增粘剂和有机液体组分,其为 与聚异丁烯和增粘剂相容。 由此,可以提供从皮肤表面去除时具有良好的皮肤粘合性,低皮肤刺激性和减轻的疼痛或粘合剂残留的粘合剂。 此外,提供粘合剂制备中比索洛尔的稳定性优异且比索洛尔的药理学有效量可以通过皮肤表面连续施用于生物体的粘合剂。 版权所有(C)2007,JPO&INPIT